New Medications in the Treatment of Nonalcoholic Steatohepatitis

​Nonalcoholic fatty liver disease, an accumulation of fat in the liver, is estimated to occur in almost 1 in 5 adults. With 2 of the most common risk factors being obesity and diabetes, its prevalence is growing. Nonalcoholic steatohepatitis is a more severe form of nonalcoholic fatty liver disease. There are currently no approved drugs to treat nonalcoholic steatohepatitis, but several drugs are being developed to treat this disease. (The full article is available as an Online First article on the Hospital Pharmacy website) 

​Track investigational drugs and find out their current status in the Prescribe Right Pharmaceutical Pipeline Tracker